SCHEMBL21687689

SCHEMBL21687689

N#Cc1ccc2c(c1)c1ccccc1n2-c1cccc(-c2c(C#N)cccc2[Si](c2ccccc2)(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP1A2 P05177 5/20 0.33
ALDH1A1 P00352 5/20 0.33
CYP3A4 P08684 4/20 0.33
LMNA P02545 4/20 0.33
CYP2D6 P10635 3/20 0.33
MAPK1 P28482 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TP53 P04637 2/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 5/20 0.33
TDP2 O95551 3/20 0.33
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
CYP2C19 P33261 2/20 0.32
CLK4 Q9HAZ1 2/20 0.32
HSD17B10 Q99714 2/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687487 0.97 LMNA (0.35) CYP1A2ALDH1A1CYP3A4LMNACYP2D6
SCHEMBL21687973 0.94 KDM4E (0.39) KDM4EATML3MBTL1ALDH1A1LMNA
SCHEMBL21687873 0.92 CYP1A2 (0.32) KDM4EATML3MBTL1CYP1A2ALDH1A1
SCHEMBL21688016 0.92 KDM4E (0.34) KDM4EATML3MBTL1CYP1A2ALDH1A1
SCHEMBL21688047 0.91 KDM4E (0.33) KDM4EATML3MBTL1CYP1A2ALDH1A1
SCHEMBL21687500 0.91 KDM4E (0.33) KDM4EATML3MBTL1CYP1A2ALDH1A1
SCHEMBL21688027 0.90 KDM4E (0.33) KDM4EATML3MBTL1CYP1A2ALDH1A1
SCHEMBL21687537 0.89 ALDH1A1 (0.34) KDM4EATML3MBTL1CYP1A2ALDH1A1
SCHEMBL21688070 0.89 PTGER4 (0.33) CYP1A2ALDH1A1CYP3A4LMNACYP2D6
SCHEMBL21687665 0.89 RARG (0.33) ALDH1A1LMNAMAPK1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 KDM4E 2977/4885ATM 1151/4885L3MBTL1 1003/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 KDM4E 2977/4885ATM 1151/4885L3MBTL1 1003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.